Testing effectiveness (Phase 2)UnknownNCT00003327What this trial is testingPaclitaxel in Treating Patients With Recurrent or Refractory Head and Neck CancerWho this might be right forHead and Neck Cancer Theradex 60
Testing effectiveness (Phase 2)Looking for participantsNCT06470217What this trial is testingTirilizumab with Albumin-bound Paclitaxel and Cisplatin for Locally Advanced Resectable Oral Squamous Cell CarcinomaWho this might be right forLocally Advanced Head and Neck Squamous Cell Carcinoma Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University 116
Large-scale testing (Phase 3)Ended earlyNCT04503668What this trial is testingOlanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology PatientsWho this might be right forGynecologic Cancer University of Michigan Rogel Cancer Center 62
Testing effectiveness (Phase 2)Looking for participantsNCT06927180What this trial is testingSHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BCWho this might be right forBreast Cancer Early Stage Breast Cancer (Stage 1-3) Henan Cancer Hospital 180
Large-scale testing (Phase 3)Looking for participantsNCT06767527What this trial is testingAK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast CancerWho this might be right forTriple-Negative Breast Cancer (TNBC) Akeso 416
Large-scale testing (Phase 3)Ended earlyNCT02470585What this trial is testingVeliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerWho this might be right forOvarian CancerOvarian Neoplasm AbbVie 1,140
Testing effectiveness (Phase 2)Looking for participantsNCT04865250What this trial is testingPredicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLCWho this might be right forNSCLC Stage IINSCLC, Stage IIIANSCLC Stage IIIB University Hospital Heidelberg 20
Testing effectiveness (Phase 2)Study completedNCT00602797What this trial is testingVinorelbine Tartrate and Paclitaxel in Treating Older Patients With Advanced Non-Small Cell Lung CancerWho this might be right forRecurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer University of Nebraska 20
Post-approval studies (Phase 4)Study completedNCT04489888What this trial is testingPembrolizumab (MK-3475) Plus Carboplatin and Paclitaxel as First-line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (MK-3475-B10/KEYNOTE B10)Who this might be right forSquamous Cell Carcinoma of Head and Neck Merck Sharp & Dohme LLC 101
Testing effectiveness (Phase 2)Study completedNCT00003540What this trial is testingGemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and PaclitaxelWho this might be right forBreast Cancer Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT04060459What this trial is testingPaclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder CancerWho this might be right forBladder Cancer Third Military Medical University 50
Testing effectiveness (Phase 2)Study completedNCT02307227What this trial is testingPhase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- TumorsWho this might be right forBreast Neoplasms Centro di Riferimento Oncologico - Aviano 46
Testing effectiveness (Phase 2)Study completedNCT00874848What this trial is testingEfficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung CancerWho this might be right forNSCLC HiberCell, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT00675259What this trial is testingPhase II NCT (Neoadjuvant Chemotherapy) w/ Weekly Abraxane in Combination With Carboplatin & Bevacizumab in Breast CancerWho this might be right forBreast Cancer Ohio State University Comprehensive Cancer Center 33
Not applicableStudy completedNCT01566461What this trial is testingIN.PACT Admiral Drug-Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA)Who this might be right forFemoral Artery StenosisPopliteal Artery StenosisFemoral Artery Occlusion+1 more Medtronic Endovascular 331
Early research (Phase 1)Study completedNCT00666991What this trial is testingPharmacokinetic, Safety and Efficacy Study of Nanoparticle Paclitaxel in Patients With Peritoneal CancersWho this might be right forPeritoneal Neoplasms CritiTech, Inc. 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06728618What this trial is testingPreoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell CarcinomaWho this might be right forOral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)Resectable Oral and Oropharyngeal Squamous Cell Carcinoma+1 more Shanghai Zhongshan Hospital
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05562297What this trial is testingNeoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic CancerWho this might be right forPancreatic Cancer, Stage IBPancreatic Cancer, Stage IIAPancreatic Cancer, Stage IIB+1 more Shanghai Zhongshan Hospital 50
Not applicableStudy completedNCT02066103What this trial is testingBroncho-Adventitial Delivery of Paclitaxel to Extend Airway Patency in Malignant Airway Obstruction PatientsWho this might be right forMalignant Airway Obstruction Secondary to Non-small Cell Lung Cancer Mercator MedSystems, Inc. 20
Testing effectiveness (Phase 2)Looking for participantsNCT06000917What this trial is testingNeoadjuvant TCHpy(Pyrotinib ,Trastuzumab,Carboplatin and Paclitaxel)for ER+/HER2+ Breast CancerWho this might be right forBreast CancerNeoadjuvant Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 62